K2 Principal Fund »

Nektar Therapeutics shares owned by K2 Principal Fund

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by K2 Principal Fund from 13F filings

Historical chart of K2 Principal Fund investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by K2 Principal Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by K2 Principal Fund

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.3M 76k 69.81

More positions owned by K2 Principal Fund

Spdr Gold Tr Gold Shs Call Option (GLD)
Allied Gold 8.750 09/07/28 '27 CVT (Principal)
Vaneck Etf Trust Junior Gold Mine Put Option (GDXJ)
State Str Spdr Sp 500 Etf T Tr Unit Call Option (SPY)
Par Technology Corp 4.000 03/15/31 CVT (Principal)
Avnet 1.750 09/01/30 Cvt Put (Principal)
Ast Spacemobile 2.375 10/15/32 CVT (Principal)
Cloudflare Note 6/1 (Principal)
Global X Fds Global X Copper Call Option (COPX)
Strategy Note 0.625 9/1 (Principal)
Abivax Sa Sponsored Ads Call Option (ABVX)
On Semiconductor Corp Note 0.500 3/0 (Principal)
Wayfair Note 3.250 9/1 (Principal)
Gamestop Corp Note 4/0 (Principal)
Pennymac Financial Services (PFSI)

View all positions for K2 Principal Fund

Top funds holding Nektar Therapeutics

FMR
Two Seas Capital
BlackRock
BVF
Susquehanna International
Vanguard Capital Management
Two Sigma Investments
Vestal Point Capital
Geode Capital Management
Prosight Management
Armistice Capital
Morgan Stanley
Millennium Management
Gilder, Gagnon, Howe & Co
Citadel Advisors

View all funds holding Nektar Therapeutics